Delay in diabetic retinopathy screening increases the rate of detection of referable diabetic retinopathy

Diabetic Medicine

Volumn 31, Issue 4, 2014, Pages 439-442

  Scanlon, P H ^a,b   Aldington, S J ^a   Stratton, I M ^a  

^a CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETIC RETINOPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; RETINA MACULOPATHY; SCREENING;

DELAYED DIAGNOSIS; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; MASS SCREENING; REFERRAL AND CONSULTATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84896128056     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12313     Document Type: Article

References (15)

1. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994; 112: 1217-1228.
2. Kohner EM, Aldington SJ, Stratton IM, Manley SE, Holman RR, Matthews DR et al. UK Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch Ophthalmol 1998; 116: 297-303.
3. Marmot M, Brunner E. Cohort profile: the Whitehall II study. Int J Epidemiol 2005; 34: 251-256.
4. Bek T, Lund-Andersen H, Hansen AB, Johnsen KB, Sandbaek A, Lauritzen T. The prevalence of diabetic retinopathy in patients with screen-detected type 2 diabetes in Denmark: the ADDITION study. Acta Ophthalmol 2009; 87: 270-274.
5. Porta M, Curletto G, Coppo E, Raviolo A, Sitia E, Albani S et al. Estimating the interval preceding diagnosis of Type 2 diabetes from the time course of retinopathy prevalence (EASDec conference abstract). Eur J Ophthalmol 2013; 23: 453.
6. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
7. Harding S, Greenwood R, Aldington S, Gibson J, Owens D, Taylor R et al. Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med 2003; 20: 965-971.
8. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98: 786-806.
9. Early Treatment Diabetic Retinopathy Study (ETDRS) Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 1991; 98: 823-833.
10. Zoega GM, Gunnarsdottir T, Bjornsdottir S, Hreietharsson AB, Viggosson G, Stefansson E. Screening compliance and visual outcome in diabetes. Acta Ophthalmol Scand 2005; 83: 687-690.
11. Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes Prim Care 2012; 14: 308-316.
12. Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care 2008; 31: 2131-2135.
13. Millett C, Dodhia H. Diabetes retinopathy screening: audit of equity in participation and selected outcomes in South East London. J Med Screen 2006; 13: 152-155.
14. Scanlon PH, Carter SC, Foy C, Husband RF, Abbas J, Bachmann MO. Diabetic retinopathy and socioeconomic deprivation in Gloucestershire. J Med Screen 2008; 15: 118-121.
15. NICE. Screening and Early Management of Diabetic Retinopathy in Type 2 Diabetes. London: National Institute for Health and Clinical Excellence, 2002.